OptiBrand Rx

Today we highlight VENCLEXTA® (venetoclax), a targeted therapy designed to help treat certain blood cancers, including chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and acute myeloid leukemia (AML).

VENCLEXTA works by targeting the BCL-2 protein, which helps cancer cells survive longer than they should. By blocking this pathway, the therapy helps trigger the natural death of cancer cells, an important shift toward more precise, mechanism-driven oncology care.

Its role in combination regimens for AML and other hematologic malignancies reflects how targeted therapies continue to reshape treatment strategies and expand options for patients navigating complex diagnoses.

OptiBrand recognizes the impact of therapies that move oncology forward through deeper biological understanding and more individualized approaches to care.

Learn more: https://www.venclexta.com/

We’re thrilled to welcome Chris Arakelian to the team as EVP, Brand Strategy & Growth at OptiBrand Rx.

Chris joins from Wolff Olins, Omnicom’s globally renowned brand consultancy, where she drove new client relationships across both established and emerging brands.

Her experience spans Healthcare and Pharma, Technology, Professional Services, Financial Services, CPG, Retail, Hospitality, Web3, and more, with 100+ wins including J&J, Kenvue, Sage Therapeutics, Uber, Instacart, SAP, Bloomberg, Morgan Stanley, Microsoft, Amazon, and ConsenSys.

Chris has also held senior roles at leading branding agencies CBX and Sterling Brands, where she helped bring category-defining mega brands to life for Unilever, J&J, Gillette, and Kimberly-Clark, including Axe, Acuvue, Venus, and U by Kotex.

Chris builds future-facing brands that resonate in a rapidly evolving global landscape. She partners closely with marketers to turn insight into action, translating research into clear positioning and creating visual and verbal systems that are compliant, distinctive, and culturally relevant.

At OptiBrand Rx, Chris brings a consultative, healthcare-focused approach grounded in human-centered research, real-world insight, and strategic rigor. She will play a key role in helping clients sharpen positioning, break category conventions, and engage stakeholders with clarity and impact.

We’re incredibly happy to have her on the team and excited for what’s ahead.